Investing.com - Zai Lab reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Zai Lab announced earnings per share of $-7.58 on revenue of $144.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of $-1.3 on revenue of $51.07M.
Zai Lab shares are down 16.39% from the beginning of the year and are trading at $52.55 , down-from-52-week-high.They are under-performing the Nasdaq which is down 13.5% from the start of the year.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings matched by Roche Holding ADR on Thursday, February 3, 2022, who reported EPS of $1.29 on revenue of $17.54B, compared to forecasts EPS of $1.29 on revenue of $17.1B.
AbbVie had beat expectations on Wednesday, February 2, 2022 with fourth quarter EPS of $3.31 on revenue of $14.89B, compared to forecast for EPS of $3.28 on revenue of $14.95B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar